|
|
Victorians urged to be part of red wine bowel cancer trial
29 May 2012
Victorians, who have a family history of bowel cancer, are being urged to take part in a study that looks at links between red wine and preventing bowel cancer.
The Royal Melbourne Hospital is looking for more participants to take part in a research trial that investigates the potential positive effects of resveratrol, a component in red wine, in reducing peoples’ risk of bowel cancer.
Head of Colorectal Medicine and Genetics at The Royal Melbourne Hospital, Professor Finlay Macrae, said bowel cancer was the second biggest cancer killer of Australians.
“Victorians have an opportunity to be part of a unique trial,” Professor Macrae said.
“We are looking for people who have an above average risk of bowel cancer, and that includes either a family history of the disease or have been diagnosed with adenomatous polyps.
“Almost 5,000 Australians lose their lives to bowel cancer annually so trials like this one are vital in helping to solve the bowel cancer puzzle.”
Research has shown that resveratrol – a polyphenolic compound in red wine – was capable of promoting a range of anti-cancer activities in vitro and in vivo studies. The randomized controlled trial compares resveratrol with placebo in patients at high risk of bowel cancer, measuring the protective effects on cells lining the bowel.
The nine-week clinical trial involves participants following a special diet and drinking 100 mls of de-alcoholised red wine each day. Participants must also be able to visit The Royal Melbourne Hospital for three short visits during the nine-week period. Participants can start the trial at a time suitable to them.
For more information about taking part in the trial contact research co-ordinator Virginia Bird on 9342 8995 or email virginia.bird@mh.org.au
Media contact: Melea Tarabay, Media Relations Manager, 03 9342 7469/ 0407 860 687
|
|
|
|
